Tecartus (brexucabtagene autoleucel)

pCPA File Number: 22340
Negotiation Status:
Concluded with an LOI
Indication(s):
For treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CADTH Project Number:
PG0304
pCPA Engagement Letter Issued:
Negotiation Process Concluded: